Analyst Devarakonda holds a conference call with CEO Patel to discuss ahead of key readouts in 1H25 in PV and PsO on February 13 at 1 pm.

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

Rep. Cory Mills, R-Fla., joins ‘The Evening Edit’ to discuss Attoney General Pam Bondi’s directives and President Donald ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $51.00 to $53.00 in a research note issued to investors on ...

周五，Truist Securities重申了对Protagonist Therapeutics (NASDAQ: PTGX )的买入评级和60.00美元的目标价。该公司目前股价为38.78美元，市值23亿美元。分析师强调了该公司药物候选者rusfertide在治疗真性红细胞增多症（PV，一种血液癌症）方面的潜力。根据InvestingPro数据，该公司保持着优秀的财务健康状况，盈利能力指标强劲。

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Protagonist Pictures is launching world sales at the EFM on Australian filmmaker Nicholas Clifford time travelling romantic ...

周五，JMP Securities重申了对Protagonist Therapeutics (NASDAQ: PTGX ...

Protagonist Pictures will launch Stan Original rom-com 'One More Shot' for international sales at this year's European Film ...